BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23671668)

  • 1. Tgf-β1 inhibits Cftr biogenesis and prevents functional rescue of ΔF508-Cftr in primary differentiated human bronchial epithelial cells.
    Snodgrass SM; Cihil KM; Cornuet PK; Myerburg MM; Swiatecka-Urban A
    PLoS One; 2013; 8(5):e63167. PubMed ID: 23671668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel amino-carbonitrile-pyrazole identified in a small molecule screen activates wild-type and ΔF508 cystic fibrosis transmembrane conductance regulator in the absence of a cAMP agonist.
    Namkung W; Park J; Seo Y; Verkman AS
    Mol Pharmacol; 2013 Sep; 84(3):384-92. PubMed ID: 23788656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low temperature and chemical rescue affect molecular proximity of DeltaF508-cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC).
    Qadri YJ; Cormet-Boyaka E; Rooj AK; Lee W; Parpura V; Fuller CM; Berdiev BK
    J Biol Chem; 2012 May; 287(20):16781-90. PubMed ID: 22442149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.
    Liu X; Jiang Q; Mansfield SG; Puttaraju M; Zhang Y; Zhou W; Cohn JA; Garcia-Blanco MA; Mitchell LG; Engelhardt JF
    Nat Biotechnol; 2002 Jan; 20(1):47-52. PubMed ID: 11753361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A truncated CFTR protein rescues endogenous DeltaF508-CFTR and corrects chloride transport in mice.
    Cormet-Boyaka E; Hong JS; Berdiev BK; Fortenberry JA; Rennolds J; Clancy JP; Benos DJ; Boyaka PN; Sorscher EJ
    FASEB J; 2009 Nov; 23(11):3743-51. PubMed ID: 19620404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis.
    Grubb BR; Gabriel SE; Mengos A; Gentzsch M; Randell SH; Van Heeckeren AM; Knowles MR; Drumm ML; Riordan JR; Boucher RC
    Am J Respir Cell Mol Biol; 2006 Mar; 34(3):355-63. PubMed ID: 16284361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of AMP-activated kinase by dysfunctional cystic fibrosis transmembrane conductance regulator in cystic fibrosis airway epithelial cells mitigates excessive inflammation.
    Hallows KR; Fitch AC; Richardson CA; Reynolds PR; Clancy JP; Dagher PC; Witters LA; Kolls JK; Pilewski JM
    J Biol Chem; 2006 Feb; 281(7):4231-41. PubMed ID: 16361706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain.
    Odolczyk N; Fritsch J; Norez C; Servel N; da Cunha MF; Bitam S; Kupniewska A; Wiszniewski L; Colas J; Tarnowski K; Tondelier D; Roldan A; Saussereau EL; Melin-Heschel P; Wieczorek G; Lukacs GL; Dadlez M; Faure G; Herrmann H; Ollero M; Becq F; Zielenkiewicz P; Edelman A
    EMBO Mol Med; 2013 Oct; 5(10):1484-501. PubMed ID: 23982976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules.
    Van Goor F; Straley KS; Cao D; González J; Hadida S; Hazlewood A; Joubran J; Knapp T; Makings LR; Miller M; Neuberger T; Olson E; Panchenko V; Rader J; Singh A; Stack JH; Tung R; Grootenhuis PD; Negulescu P
    Am J Physiol Lung Cell Mol Physiol; 2006 Jun; 290(6):L1117-30. PubMed ID: 16443646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia.
    Sun F; Mi Z; Condliffe SB; Bertrand CA; Gong X; Lu X; Zhang R; Latoche JD; Pilewski JM; Robbins PD; Frizzell RA
    FASEB J; 2008 Sep; 22(9):3255-63. PubMed ID: 18556464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The short apical membrane half-life of rescued {Delta}F508-cystic fibrosis transmembrane conductance regulator (CFTR) results from accelerated endocytosis of {Delta}F508-CFTR in polarized human airway epithelial cells.
    Swiatecka-Urban A; Brown A; Moreau-Marquis S; Renuka J; Coutermarsh B; Barnaby R; Karlson KH; Flotte TR; Fukuda M; Langford GM; Stanton BA
    J Biol Chem; 2005 Nov; 280(44):36762-72. PubMed ID: 16131493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers.
    Bebok Z; Collawn JF; Wakefield J; Parker W; Li Y; Varga K; Sorscher EJ; Clancy JP
    J Physiol; 2005 Dec; 569(Pt 2):601-15. PubMed ID: 16210354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.
    Luciani A; Villella VR; Esposito S; Gavina M; Russo I; Silano M; Guido S; Pettoello-Mantovani M; Carnuccio R; Scholte B; De Matteis A; Maiuri MC; Raia V; Luini A; Kroemer G; Maiuri L
    Autophagy; 2012 Nov; 8(11):1657-72. PubMed ID: 22874563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β1 Inhibition of ACE2 Mediated by miRNA Uncovers Novel Mechanism of SARS-CoV-2 Pathogenesis.
    Hejenkowska ED; Mitash N; Donovan JE; Chandra A; Bertrand C; De Santi C; Greene CM; Mu F; Swiatecka-Urban A
    J Innate Immun; 2023; 15(1):629-646. PubMed ID: 37579743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of kinase inhibitors to correct ΔF508-CFTR function.
    Trzcinska-Daneluti AM; Nguyen L; Jiang C; Fladd C; Uehling D; Prakesch M; Al-awar R; Rotin D
    Mol Cell Proteomics; 2012 Sep; 11(9):745-57. PubMed ID: 22700489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers.
    Rowe SM; Pyle LC; Jurkevante A; Varga K; Collawn J; Sloane PA; Woodworth B; Mazur M; Fulton J; Fan L; Li Y; Fortenberry J; Sorscher EJ; Clancy JP
    Pulm Pharmacol Ther; 2010 Aug; 23(4):268-78. PubMed ID: 20226262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells.
    Suaud L; Miller K; Alvey L; Yan W; Robay A; Kebler C; Kreindler JL; Guttentag S; Hubbard MJ; Rubenstein RC
    J Biol Chem; 2011 Jun; 286(24):21239-53. PubMed ID: 21525008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathway.
    Yi S; Pierucci-Alves F; Schultz BD
    Am J Physiol Cell Physiol; 2013 Oct; 305(8):C867-76. PubMed ID: 23903699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cl transport in complemented CF bronchial epithelial cells correlates with CFTR mRNA expression levels.
    Illek B; Maurisse R; Wahler L; Kunzelmann K; Fischer H; Gruenert DC
    Cell Physiol Biochem; 2008; 22(1-4):57-68. PubMed ID: 18769032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.